Home
gpo.gov
govinfo.gov

e-CFR Navigation Aids

Browse

Simple Search

Advanced Search

 — Boolean

 — Proximity

 

Search History

Search Tips

Corrections

Latest Updates

User Info

FAQs

Agency List

Incorporation By Reference

eCFR logo

Related Resources

The Code of Federal Regulations (CFR) annual edition is the codification of the general and permanent rules published in the Federal Register by the departments and agencies of the Federal Government produced by the Office of the Federal Register (OFR) and the Government Publishing Office.

Download the Code of Federal Regulations in XML.

Download the Electronic Code of Federal Regulations in XML.

Monthly Title and Part user viewing data for the e-CFR is available for download in CSV format.

Parallel Table of Authorities and Rules for the Code of Federal Regulations and the United States Code
Text | PDF

Find, review, and submit comments on Federal rules that are open for comment and published in the Federal Register using Regulations.gov.

Purchase individual CFR titles from the U.S. Government Online Bookstore.

Find issues of the CFR (including issues prior to 1996) at a local Federal depository library.

[A2]

Electronic Code of Federal Regulations

We invite you to try out our new beta eCFR site at https://ecfr.federalregister.gov. We’ve made big changes to make the eCFR easier to use. Be sure to leave feedback using the Help button on the bottom right of each page!

e-CFR data is current as of August 7, 2020

Title 21 → Chapter I → Subchapter D → Part 316

TITLE 21—Food and Drugs

CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)

SUBCHAPTER D—DRUGS FOR HUMAN USE

PART 316—ORPHAN DRUGS

rule

Subpart A—GENERAL PROVISIONS

§316.1
Scope of this part.
§316.2
Purpose.
§316.3
Definitions.
§316.4
Address for submissions.
rule

Subpart B—WRITTEN RECOMMENDATIONS FOR INVESTIGATIONS OF ORPHAN DRUGS

§316.10
Content and format of a request for written recommendations.
§316.12
Providing written recommendations.
§316.14
Refusal to provide written recommendations.
rule

Subpart C—DESIGNATION OF AN ORPHAN DRUG

§316.20
Content and format of a request for orphan-drug designation.
§316.21
Verification of orphan-drug status.
§316.22
Permanent-resident agent for foreign sponsor.
§316.23
Timing of requests for orphan-drug designation; designation of already approved drugs.
§316.24
Deficiency letters and granting orphan-drug designation.
§316.25
Refusal to grant orphan-drug designation.
§316.26
Amendment to orphan-drug designation.
§316.27
Change in ownership of orphan-drug designation.
§316.28
Publication of orphan-drug designations.
§316.29
Revocation of orphan-drug designation.
§316.30
Annual reports of holder of orphan-drug designation.
rule

Subpart D—ORPHAN-DRUG EXCLUSIVE APPROVAL

§316.31
Scope of orphan-drug exclusive approval.
§316.34
FDA recognition of exclusive approval.
§316.36
Insufficient quantities of orphan drugs.
rule

Subpart E—OPEN PROTOCOLS FOR INVESTIGATIONS

§316.40
Treatment use of a designated orphan drug.
rule

Subpart F—AVAILABILITY OF INFORMATION

§316.50
Guidance documents.
§316.52
Availability for public disclosure of data and information in requests and applications.

Need assistance?